Coronavirus cases in India: a total of 11,039 new cases were registered on Wednesday (archive) New Delhi: About one in four of India’s 135 million people may have been infected with the coronavirus, said a source with direct knowledge of a government serosurvey, suggesting that the country’s actual case burden …
Read More »India’s Covid-19 Vaccination Campaign Starts Today – All Your Questions Answered
The world’s largest vaccination campaign against the new coronavirus will begin on Saturday when India begins vaccinating three million million of its front-line workers. In the first phase, two indigenous vaccines, Covaxin and Covishield, will be administered to the priority groups. More than one crore and 5.27 lakh people have …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »Oxford COVID-19 Covishield Vaccine, Bharat Biotech’s Covaxin Gain DCGI Approval for Emergency Use
The indigenous vaccine developed by Bharat Biotech with the Indian Council for Medical Research (ICMR) will be used as a ‘backup’, only if the country needs additional doses to vaccinate large numbers of people, particularly given the possibility of an increase sudden triggered by the UK variant. And, unlike the …
Read More »Panel authorizes Covishield firing, last step before regulator approval
A committee of experts from the country’s top drug regulator recommended on Friday that Covishield, the Indian version of the Covid-19 vaccine developed by the University of Oxford and AstraZeneca, should be approved under certain conditions, The Indian Express has learned. The recommendation is hugely significant as it paves the …
Read More »Oxford-AstraZeneca Covid Vaccine To Become First To Get Approved In India
India’s drug regulator will approve a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, three sources with knowledge of the matter said. The decision would pave the way for the launch of the vaccine in the second most populous country in the world, which, after …
Read More »Serum Institute expects regulatory approval for Oxford coronavirus vaccine in a few days
The Serum Institute of India, which is manufacturing and testing the Oxford / AstraZeneca coronavirus vaccine in the country, said Monday. awaited regulatory approval to take in a few days. Serum CEO Adar Poonawalla said the vaccine, called Covishield in India, should be licensed by January. “The emergency use authorization …
Read More »Frontline staff, over 50, youth at risk
Written by Kaunain Sheriff M | New Delhi | Updated: December 9, 2020 10:03:07 am At the Serum Institute of India on Monday. (Photo: Reuters) One crore of health workers, two crore of frontline workers, including the police and armed forces, and around 27 crore of people over 50 and …
Read More »3 Covid-19 Vaccine Developers Seek Emergency Use Approval In India
Written by Kaunain Sheriff M, Amitabh Sinha | New Delhi, Pune | Updated: December 9, 2020 10:02:09 am Vials of Covishield, the Indian version of the AstraZeneca-Oxford vaccine, at the Serum Institute of India in Pune, India. (Reuters photo) Three vaccine developers have submitted applications to the Central Drug Standards …
Read More »Details emerge on Covid-19 vaccination in India
Written by Kaunain Sheriff M | New Delhi | Updated: December 8, 2020 7:53:42 am States are also uploading data on 2.39 lakhs of vaccinators, many of whom are assistant nurse midwives (ANM), on the digital platform, the sources said. The vaccine will be administered to 100 people during each …
Read More »